label int64 1 1 | id stringlengths 10 12 | original_id stringlengths 8 9 | text stringlengths 347 29.5k |
|---|---|---|---|
1 | 172539239_0 | 172539239 | CORPORACION AMERICA AIRPORTS S.A.
Form 20-F
Filed on 27-Apr-2018 Period 31-Dec-2017 Accession number: 0001144204-18-023178
Included Items
1. 20-F: FORM 20-F 2. EX-1.1: EXHIBIT 1.1 3. EX-8.1: EXHIBIT 8.1 4. EX-12.1: EXHIBIT 12.1 5. EX-12.2: EXHIBIT 12.2 6. EX-13.1: EXHIBIT 13.1 7. EX-13.2: EXHIBIT 13.2
UNITED STATES... |
1 | 172539239_1 | 172539239 | , 2017
OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934 For the transition period from __________ to ___________ OR
¨ SHELL COMPANYREPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934 Date of event requiring this shell company report ______________
C... |
1 | 172539239_2 | 172539239 | exchange in which registered New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as... |
1 | 172539239_3 | 172539239 | ) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
¨ Yes x No
Indicate by check mark whether the registrant has submitted electronically ... |
1 | 172539239_b0 | 172539239 | ES-OXLEYACT OF 2002
In connection with the Annual Report of Corporación América Airports S.A. (the "Company") on Form 20-F for the fiscal year ended December 31, 2017, as filed with the U.S. Securities and Exchange Commission on the date hereof (the "Report"), I, Martín Francisco Antranik Eurnekian, Chief Executive Off... |
1 | 172539239_b1 | 172539239 | has materially affected, or is reasonably likely to materially affect the company's internal control over financial reporting.
5. The company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's
auditors and the audit c... |
1 | 172540039_0 | 172540039 | Adecoagro S.A.
Form 20-F
Filed on 27-Apr-2018 Period 31-Dec-2017 Accession number: 0001628280-18-005268
Included Items
1. 20-F 2. EX-1.1: EXHIBIT 1.1 3. EX-4.43: EXHIBIT 4.43 4. EX-8.1: EXHIBIT 8.1 5. EX-12.1: EXHIBIT 12.1 6. EX-12.2: EXHIBIT 12.2 7. EX-13.1: EXHIBIT 13.1 8. EX-13.2: EXHIBIT 13.2 9. EX-15.1: EXHIBIT ... |
1 | 172540039_1 | 172540039 | OF 1934
OR
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934 FOR THEFISCAL YEAR ENDED ON DECEMBER 31, þ 2017
OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934
FOR THETRANSITION PERIOD FROM
TO ________________
OR
¨ SHELL COMPANYREPORT PU... |
1 | 172540039_2 | 172540039 | Naos Building, 6, Rue Eugène Ruppert, L - 2453 Luxembourg Email: catherine.Drissens@intertrustgroup.com Tel: +352.26449.167 (Name, Telephone, E-Mail and/or Facsimile number and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of Each Class
Name ... |
1 | 172540039_3 | 172540039 | of the Securities Exchange Act of
1934. Yes ¨ No þ Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports)... |
1 | 172540039_b0 | 172540039 | .50%
Perpetuity growth rate
2.00%
2.00%
UMA
Disclosure of information for cash-generating units [line items]
Financial projections (in years)
4 years 4 years
AVI
Disclosure of information for cash-generating units [line items]
Financial projections (in years)
7 years 7 years
Bottom of range
Disclosure of i... |
1 | 172540039_b1 | 172540039 | -generating units [line items]
Goodwill
2,622
2,564
Brazil
Disclosure of information for cash-generating units [line items]
Goodwill
$ 7,317
$ 7,425
Brazil | Cash-generating units
Disclosure of information for cash-generating units [line items]
Goodwill
7,634
7,456
Closing net book value of PPE items and ... |
1 | 172543714_0 | 172543714 | MATERIALISE NV
Form 20-F
Filed on 30-Apr-2018 Period 31-Dec-2017 Accession number: 0001193125-18-143179
Included Items
1. 20-F 2. EX-1.1 3. EX-4.9 4. EX-8.1 5. EX-12.1 6. EX-12.2 7. EX-13.1 8. EX-13.2 9. EX-23.1
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
R... |
1 | 172543714_1 | 172543714 | THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 001-36515
MATERIALISE NV
(Exact name of Registrant as specified in its charter)
Not Applicable
(Translation of Registrant's name into English)
Kingdom of Belgium
(Jurisdiction of incorporation or organization)
Technologielaan 15, 3001 Leuven, Belgium
(Addres... |
1 | 172543714_2 | 172543714 | to the requirements of the Securities and Exchange Commission. Securities registered or to be registered pursuant to Section 12(g) of the Act: None.
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None.
The number of outstanding shares of each of the issuer's classes of capi... |
1 | 172543714_3 | 172543714 | shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes
No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be... |
1 | 172543714_b0 | 172543714 | my knowledge: (i) the Report fully complies with the requirements of section 13(a) or 15(d) of the U.S. Securities Exchange Act of 1934, as amended; and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: April ... |
1 | 172543714_b1 | 172543714 | over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over finan... |
1 | 172543848_0 | 172543848 | Forward Pharma A/S
Form 20-F
Filed on 30-Apr-2018 Period 31-Dec-2017 Accession number: 0001047469-18-003354
Included Items
1. 20-F 2. EX-8.1 3. EX-12.1 4. EX-12.2 5. EX-13.1 6. EX-15.1 7. XBRL (render)
Use these links to rapidly review the document TABLE OF CONTENTS Forward Pharma A/S
Table of Contents
UNITED STATE... |
1 | 172543848_1 | 172543848 | COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report............... Commission file number 001-36686
Forward Pharma A/S (Exact name of Registrant as specified in its charter)
Forward Pharma A/S (Translation of Registrant's name into E... |
1 | 172543848_2 | 172543848 | represents two ordinary shares
Each ADS represents two ordinary shares Securities registered or to be registered pursuant to Section 12(g) of the Act.
Not Applicable (Title of Class)
Table of Contents Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.
Not Applicable
(Titl... |
1 | 172543848_3 | 172543848 | whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 day... |
1 | 172543848_b0 | 172543848 | 000
Consultant two | Deferred shares
Disclosure of transactions
between related parties [line
items]
Shares outstanding | EquityInstruments
194,000
Board of Directors
Disclosure of transactions
between related parties [line
items]
Compensation
$ 373,000
$ 87,000
$ 35,000
Share - based compensation
1,300... |
1 | 172543848_b1 | 172543848 | parties
0
Share - based compensation paid
$ 223,000
$ 3,290,000
$ 5,500,000
Deferred shares
Disclosure of transactions
between related parties [line
items]
Granted | EquityInstruments
55,000
Shares outstanding | EquityInstruments
700,000
3,517,000
4,814,000
5,686,000
Granted (after Share Split) | Equi... |
1 | 172544002_0 | 172544002 | NATUZZI S P A
Form 20-F
Filed on 30-Apr-2018 Period 31-Dec-2017 Accession number: 0001193125-18-143394
Included Items
1. 20-F: FORM 20-F 2. EX-4.8 3. EX-4.9 4. EX-8.1 5. EX-12.1 6. EX-12.2 7. EX-13.1
Table of Contents
Natuzzi S.p.A
Annual Report on Form 20-F 2017
Table of Contents
UNITED STATES SECURITIES AND E... |
1 | 172544002_1 | 172544002 | 70029, Santeramo in Colle, Bari, Italy
(Address of principal executive offices)
Mr. Pietro Direnzo Tel.: +39 080 8820 812; pdirenzo@natuzzi.com; Via Iazzitiello 47, 70029 Santeramo in Colle, Bari, Italy
(Name, telephone, e-mail and/or facsimile number and address of company contact person)
Securities registered or to ... |
1 | 172544002_2 | 172544002 | , 2017 54,853,045 Ordinary Shares
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) ... |
1 | 172544002_3 | 172544002 | Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer Non-a... |
1 | 172544002_b0 | 172544002 | or is reasonably likely to materially affect, the company's internal control over financial reporting; and
5. The company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of the compan... |
1 | 172544002_b1 | 172544002 | (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our ... |
1 | 172544082_0 | 172544082 | EDAP TMS SA
Form 20-F
Filed on 30-Apr-2018 Period 31-Dec-2017 Accession number: 0001171843-18-003197
Included Items
1. 20-F: FORM 20-F 2. EX-1.1: EXHIBIT 1.1 3. EX-8.1: EXHIBIT 8.1 4. EX-12.1: EXHIBIT 12.1 5. EX-12.2: EXHIBIT 12.2 6. EX-13.1: EXHIBIT 13.1 7. EX-15.1: EXHIBIT 15.1 8. XBRL (render)
As filed with the ... |
1 | 172544082_1 | 172544082 | the Fiscal Year Ended December 31, 2017
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIESEXCHANGE ACT OF 1934 For the transition period from ________ to _________
OR
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIESEXCHANGE ACT OF 1934 Date of the event requiring this shel... |
1 | 172544082_2 | 172544082 | 69120 Vaulx-en-Velin, France
(Name, Telephone, E-mail and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange on which registered
American Depositary Shares, each representing One Ordinary Share
Ordinary Share... |
1 | 172544082_3 | 172544082 |
Yes _______
No ___X___
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports) and (2) has been subje... |
1 | 172544082_b0 | 172544082 | (4,131)
Balance
14,266
19,450
19,212
SEC Schedule, 12-09, Allowance, Credit Loss [Member]
Balance
960
1,091
1,274
Charges to costs and expenses
69
103
124
Deductions: write-off and others
(233)
(307)
Balance
1,029
960
1,091
SEC Schedule, 12-09, Reserve, Inventory [Member]
Balance
803
728
741
C... |
1 | 172544082_b1 | 172544082 |
Segment operating income (loss)
(311)
Total Assets
Capital expenditures
Long-lived assets
Goodwill
FDA [Member] | Product [Member]
Revenues
FDA [Member] | HIFU Treatments and Devices Leased [Member]
Revenues
FDA [Member] | Parts and Services [Member]
Revenues
FDA [Member] | Product and Services, Excluding ... |
1 | 172544372_0 | 172544372 | Nexa Resources S.A.
Form 20-F
Filed on 30-Apr-2018 Period 31-Dec-2017 Accession number: 0001104659-18-028667
Included Items
1. 20-F 2. EX-8 3. EX-12.1 4. EX-12.2 5. EX-13.1
Table of Contents
As filed with the Securities and Exchange Commission on April 30, 2018
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Was... |
1 | 172544372_1 | 172544372 | L-2540, Luxembourg Grand Duchy of Luxembourg (Address of principal executive offices)
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Common shares, each with par value of US$1.00
Name of Each Exchange on Which Registered New York Stock Exchange
Securities registe... |
1 | 172544372_2 | 172544372 | to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
Yes x No o
Indicate by check mark whether the registra... |
1 | 172544372_3 | 172544372 | an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
... |
1 | 172544372_b0 | 172544372 | the period covered by this report based on such evaluation; and
(c) Disclosed in this report any change in the company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's inter... |
1 | 172544372_b1 | 172544372 | report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statemen... |
1 | 172544577_0 | 172544577 | Merus N.V.
Form 20-F
Filed on 30-Apr-2018 Period 31-Dec-2017 Accession number: 0001193125-18-143856
Included Items
1. 20-F: FORM 20-F 2. EX-1.1 3. EX-4.1 4. EX-4.2 5. EX-4.3 6. EX-4.7 7. EX-4.8 8. EX-4.9 9. EX-4.10 10. EX-4.11 11. EX-4.12 12. EX-4.15.1 13. EX-4.19 14. EX-12.1 15. EX-12.2 16. EX-13.1 17. EX-13.2 18. E... |
1 | 172544577_1 | 172544577 | OF 1934
OR
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934
For the fiscal year ended December 31, 2017
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934
For the transition period from
to
OR
SHELL COMPANYREPORT PURSUANT TO SECTION 13... |
1 | 172544577_2 | 172544577 | 800
(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class Common shares, nominal value 0.09 per share
Name of each exchange on which registered The Nasdaq Stock Market LLC
Securities ... |
1 | 172544577_3 | 172544577 | No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requ... |
1 | 172544577_b0 | 172544577 | closure of finance lease and operating lease by lessee [line items]
Minimumlease payments payable under non cancellable operating lease 2,499
Less than one year [member]
Disclosure of finance lease and operating lease by lessee [line items]
Minimumlease payments payable under non cancellable operating lease 602
B... |
1 | 172544577_b1 | 172544577 | between related parties [line items]
Ownership interest held by shareholders
5.00%
Bottom of range [member] | Sofinnova Venture Partners Nine Limited Partnership [member]
Disclosure of transactions between related parties [line items]
Ownership interest held by shareholders
5.00%
Top of range [member] | Biophra... |
1 | 172602064_0 | 172602064 | BT GROUP PLC
Form 20-F
Filed on 24-May-2018 Period 31-Mar-2018 Accession number: 0001193125-18-172711
Included Items
1. 20-F 2. EX-7.1 3. EX-12.1 4. EX-12.2 5. EX-13.1 6. EX-15.1 7. EX-15.2 8. EX-15.3 9. EX-15.4
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
(... |
1 | 172602064_1 | 172602064 | SUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
For the transition period from
to
Commission File Number: 1-08819
BT Group plc
(Exact name of Registrant as specified in its charter)
Not Applicable
(Translation of Registrant's name into English)... |
1 | 172602064_2 | 172602064 | NewYork Stock Exchange*
* Not for trading, but only in connection with the registration of American Depositary Shares representing these shares, pursuant to the requirements of the Securities and Exchange Commission.
Securities registered or to be registered pursuant to Section 12(g) of the Act: None
Securities for wh... |
1 | 172602064_3 | 172602064 | Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requireme... |
1 | 172602064_b0 | 172602064 | None of the reports of PwC on those financial statements contained an adverse opinion or disclaimer of opinion, or was qualified or modified as to uncertainty, audit scope or accounting principles.
During those fiscal years there were no disagreements with PwC, whether or not resolved, on any matter of accounting prin... |
1 | 172602064_b1 | 172602064 | London Stock Exchange in 1984 and PwC's reappointment had not been subject to a tender until 2017 when the Audit & Risk Committee recommended to the Board that an audit tender process be undertaken with a view to appointing a new auditor for the financial year 2018/19. PwC advised the Audit & Risk Committee on 11 Apri... |
1 | 172639425_0 | 172639425 | Castle Brands Inc
Form 10-K
Filed on 14-Jun-2018 Period 31-Mar-2018 Accession number: 0001493152-18-008701
Included Items
1. 10-K 2. EX-21.1 3. EX-23.1 4. EX-31.1 5. EX-31.2 6. EX-32.1 7. XBRL (render)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
[X] ANNUAL REPORT PURSUANT TO ... |
1 | 172639425_1 | 172639425 | S. Employer Identification No.)
122 East 42nd Street, Suite 5000 NewYork, NewYork
(Address of principal executive offices)
10168 (Zip Code)
Registrant's telephone number, including area code (646) 356-0200
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class Common stock, $0.01 par value... |
1 | 172639425_2 | 172639425 | been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§229.405 of thi... |
1 | 172639425_3 | 172639425 | .
[ ] Large accelerated filer [ ] Non-accelerated filer [ ] Emerging growth company
[X] Accelerated filer [ ] Smaller reporting company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial account... |
1 | 172639425_b0 | 172639425 | ,375) (469,798) (210,856) (170,116) 1,089,124 1,359,145 809,662
Net (loss) income attributable to common Stockholders
$ (336,434)
$ 465,580
$ (1,682)
$ (946,396) $ 191,350
$ 422,566
$ (700,710)
$ (765,819)
$ (818,932)
$ (852,613)
$ (2,516,368)
Net (loss) income per common share, basic, attributable to $ (0.... |
1 | 172639425_b1 | 172639425 |
$
$
$
[1] $
[1] $
[1]
24,071,457 24,079,623 20,894,150 20,852,287 22,580,876 18,309,539 19,627,791 16,750,925 89,897,517 77,269,131 72,220,368
Gross profit
9,407,147 9,677,937 8,534,249 8,578,619 9,586,742 7,670,240 7,727,260 6,716,115 36,206,952 31,700,357 28,553,570
Net (loss) income
190,185 664,603 280,6... |
1 | 172650461_0 | 172650461 | Medtronic Plc
Form 10-K
Filed on 22-Jun-2018 Period 27-Apr-2018 Accession number: 0001613103-18-000024
Included Items
1. 10-K 2. EX-10.50: EXHIBIT 10.50 3. EX-10.51: EXHIBIT 10.51 4. EX-10.52: EXHIBIT 10.52 5. EX-10.53: EXHIBIT 10.53 6. EX-12.1: COMPUTATION OF RATIO OF
EARNINGS TO FIXED CHARGES 7. EX-21: LIST OF SUBS... |
1 | 172650461_1 | 172650461 | .2: CERTIFICATION OF CFO
PURSUANT TO SECTION 906 14. XBRL (render)
Table of Contents
UNITED STATES SECURITIES AND EXCHANGECOMMISSION
Washington, D.C. 20549
FORM 10-K
x
Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934.
For the fiscal year ended April 27, 2018.
o
Transition rep... |
1 | 172650461_2 | 172650461 |
Title of each class
Ordinary shares, par value $0.0001 per share
Securities registered pursuant to section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o
Name of each exchange on which registered NewYork Sto... |
1 | 172650461_3 | 172650461 | preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant's knowledge, in... |
1 | 172650461_b0 | 172650461 | 2,668 $ 4,929
(3,471) 113 (518) 3,339
2,821
4,114
(1,266)
(1,046) (5,406) 9,924 0 0 (14) 2,192
(22) 7 0 0
(3,011) 0 0 0 (6,163) (4,005) 5,679 82 (7,433) 113 (1,014) 3,682 $ 2,668
Schedule II (Details) - USD ($)
$ in Millions
12 Months Ended Apr. 27, 2018 Apr. 28, 2017 Apr. 29, 2016
Allowance for Doubtful Accounts... |
1 | 172650461_b1 | 172650461 | )
Dividends to shareholders
0
Issuance of ordinary shares
0
Repurchase of ordinary shares
0
Net intercompany loan borrowings (repayments)
(9,969)
Intercompany dividend paid
(1,048)
Capital contributions received
5,757
Other financing activities
(2)
Net cash used in financing activities
(11,597)
Effect ... |
1 | 172658669_0 | 172658669 | Modern Media Acquisition Corp.
Form 10-K
Filed on 28-Jun-2018 Period 31-Mar-2018 Accession number: 0001193125-18-206296
Included Items
1. 10-K: FORM 10-K 2. EX-31.1: EXHIBIT 31.1 3. EX-31.2: EXHIBIT 31.2 4. EX-32.1: EXHIBIT 32.1 5. EX-32.2: EXHIBIT 32.2 6. XBRL (render)
Table of Contents
UNITED STATES SECURITIES A... |
1 | 172658669_1 | 172658669 |
MODERN MEDIA ACQUISITION CORP.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or other jurisdiction of incorporation)
47-1277598
(IRS Employer Identification No.)
1180 Peachtree Street, N.E. Suite 2400 Atlanta, GA
(Address of principal executive offices)
30309
(Zip Code)
Registrant's tele... |
1 | 172658669_2 | 172658669 | daq Capital Market
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES NO
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d)... |
1 | 172658669_3 | 172658669 | check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405) is not contained herein, and will not be contained, to the best of Registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form ... |
1 | 172658669_b0 | 172658669 | ,653 $ 158,106 $ (615) $ 340 $ 302 $ 297 $ 670,812 $ 324 $ 1,187
Loss (income) fromoperations (144,061) (194,992) (173,653) (158,106) 615 (340) (302) (297) (670,812) (324)
(1,187)
Interest income
604,453 474,396 429,200 50,860
1,558,909
Net income (loss)
$ 306,569
$ 126,944
$ 126,327
$ (107,246)
$
615
$ (3... |
1 | 172658669_b1 | 172658669 | net of federal tax benefit
0.00%
Change in valuation allowance
17.50%
Income tax provision
49.00%
Fair Value Measurements Summary of Assets
Measured at Fair Value on Recurring Basis (Detail)
Mar. 31, 2018 USD ($)
Assets:
Cash and marketable securities held in Trust Account $ 210,502,923
Fair Value, Inputs, ... |
1 | 172687161_0 | 172687161 | Akari Therapeutics Plc
Form 20-F
Filed on 18-Jul-2018 Period 31-Dec-2017 Accession number: 0001144204-18-038891
Included Items
1. 20-F: FORM 20-F 2. EX-10.19: EXHIBIT 10.19 3. EX-10.20: EXHIBIT 10.20 4. EX-21.1: EXHIBIT 21.1 5. EX-23.1: EXHIBIT 23.1 6. EX-23.2: EXHIBIT 23.2 7. EX-31.1: EXHIBIT 31.1 8. EX-31.2: EXHIBI... |
1 | 172687161_1 | 172687161 | ) OR (g) OF THESECURITIES EXCHANGEACT OF 1934 OR
x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934 For the fiscal year ended December 31, 2017 OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934 OR
¨ SHELL COMPANYREPORT PURSUANT TO SECTION 13 OR... |
1 | 172687161_2 | 172687161 | , E-mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class
American Depositary Shares, each representing 100 Ordinary Shares, par value
£0.01 per share
Ordinary Shares, £0.01 par value per share*
Name of e... |
1 | 172687161_3 | 172687161 | Yes x No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
¨ Yes x No
Note Checking the box above will not relieve any registrant required to file reports pursuant to Sec... |
1 | 172687161_b0 | 172687161 | Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 19.25% 20.00% 20.25%
Effective Income Tax Rate Reconciliation, Tax Credit, Amount, Total
$ 3,800,000
Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total
14.50%
Foreign Tax Authority [Member]
Operating Loss Carryforwards [Line... |
1 | 172687161_b1 | 172687161 | 596
Change of tax rate due to U.S. tax reform
2,506,519 0
0
Tax rate difference in foreign jurisdictions
(697,127) 2,341,113 (1,964,914)
Income tax expense
$ 0
$ 0
$ 0
Taxes (Details 3) - USD ($) Dec. 31, 2017 Dec. 31, 2016
Deferred tax assets
Stock-based compensation
$ 1,464,527 $ 994,618
Litigation set... |
1 | 172715168_0 | 172715168 | Seagate Technology Plc
Form 10-K
Filed on 03-Aug-2018 Period 29-Jun-2018 Accession number: 0001193125-18-238271
Included Items
1. 10-K 2. EX-10.52 3. EX-21.1 4. EX-23.1 5. EX-31.1 6. EX-31.2 7. EX-32.1 8. XBRL (render)
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 1... |
1 | 172715168_1 | 172715168 | (State or other jurisdiction of incorporation or organization)
98-0648577 (I.R.S. Employer Identification Number)
38/39 Fitzwilliam Square Dublin 2, Ireland
(Address of principal executive offices)
Registrant's telephone number, including area code: (353) (1) 234-3136
Securities registered pursuant to Section 12 (... |
1 | 172715168_2 | 172715168 | (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES NO
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File r... |
1 | 172715168_3 | 172715168 | " and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer Non-accelerated filer Emerging growth company
(Do not check if a smaller reporting company)
Accelerated filer
Smaller reporting company
If an emerging growth company, indicate by check mark if the regist... |
1 | 172715168_b0 | 172715168 | minimumlease payments for operating leases $ 109
Guarantees (Narrative) (Details)
12 Months Ended
Jun. 29, 2018 USD ($)
Schedule of Fiscal Years [Line Items]
intellectual property indemnification obligations $ 0
intellectual property indemnification obligations $ 0
Minimum [Member]
Schedule of Fiscal Years [Li... |
1 | 172715168_b1 | 172715168 | ($) $ in Millions
12 Months Ended Jun. 29, 2018 Jun. 30, 2017 Jul. 01, 2016
Leases [Abstract]
Total rent expense for all land, facility and equipment operating leases, net of sublease income $ 22
$ 29
$ 43
Total sublease rental income
3
$ 2
$ 3
Total future lease income to be recognized for existing sublease... |
1 | 172728956_0 | 172728956 | CIMPRESS N.V.
Form 10-K
Filed on 10-Aug-2018 Period 30-Jun-2018 Accession number: 0001262976-18-000052
Included Items
1. 10-K 2. EX-3.1: EXHIBIT 3.1 ARTICLES OF
ASSOCIATION 3. EX-10.28: EXHIBIT 10.28 AMENDMENT NO.9
TO EMPLOYMENT AGREEMENT WITH ROBERT S. KEANE 4. EX-21.1: EXHIBIT 21.1 SUBSIDIARIES OF CIMPRESS N.V. 5. ... |
1 | 172728956_1 | 172728956 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________
Form 10-K
(Mark One)
þ
ANNUAL REPORT PURSUANT TOSECTION13 OR15(d) OFTHESECURITIES EXCHANGEACT OF1934
For the fiscal year ended June 30, 2018
or
o
TRANSITIONREPORT PURSUANT TOSECTION13 OR15(d) OFTHESECURIT... |
1 | 172728956_2 | 172728956 | Securities Registered Pursuant to Section 12(b) of the Act:
Title of Each Class
Name of Exchange on Which Registered
OrdinaryShares, 0.01 par value
NASDAQ Global Select Market
Securities registered pursuant to Section 12(g) of the Act: None
_________________________________
Indicate by check mark if the registr... |
1 | 172728956_3 | 172728956 | pursuant to Rule 405 of Regulation S-T(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item405 of Regulation S-K is not contained here... |
1 | 172728956_b0 | 172728956 | 585 576,851 443,713 2,613,545 2,141,095 1,788,044
Revenue
2,592,541 2,135,405 1,788,044
Cost of revenue
316,550 319,209 360,285 283,755 279,077 268,482 276,366 213,050 1,279,799 [1] 1,036,975 [1] 773,640 [1]
Net income (loss)
(5,639) (1,602) 30,623 23,406 (34,513) (42,678) 35,022 (30,030) 46,788 (72,199) 50,411
... |
1 | 172728956_b1 | 172728956 |
Restructuring Cost and Reserve [Line Items]
Restructuring Charges
$ 1,116
Other Restructuring [Member] | Central and corporate costs
Restructuring Cost and Reserve [Line Items]
Restructuring Charges
$ 56
[1] Share-based compensation is allocated as follows:
Quarterly Financial Data (unaudited) (Details) - USD... |
1 | 172762682_0 | 172762682 | Atlassian Corp Plc
Form 20-F
Filed on 30-Aug-2018 Period 30-Jun-2018 Accession number: 0001650372-18-000038
Included Items
1. 20-F 2. EX-12.1: EXHIBIT 12.1 3. EX-12.2: EXHIBIT 12.2 4. EX-12.3: EXHIBIT 12.3 5. EX-13.1: EXHIBIT 13.1 6. EX-13.2: EXHIBIT 13.2 7. EX-13.3: EXHIBIT 13.3 8. EX-21.1: EXHIBIT 21.1 9. EX-23.1: ... |
1 | 172762682_1 | 172762682 | SUANT TO SECTION 13 OR15(d) OF THESECURITIES EXCHANGEACT OF 1934
For the fiscal year ended June 30, 2018
OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR15(d) OF THESECURITIES EXCHANGEACT OF 1934
OR
¨ SHELLCOMPANYREPORT PURSUANT TO SECTION 13 OR15(d) OF THESECURITIES EXCHANGEACT OF 1934
Commission File Number 001-37651... |
1 | 172762682_2 | 172762682 | Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange on which registered
Class A Ordinary Shares
NASDAQ Global Select Market
Securities registered or to be registered pursuant to Section 12(g) of the Act: None Securities for whichthere is a repor... |
1 | 172762682_3 | 172762682 | reports pursuant to Section 13 or 15(d) ofthe Securities Exchange Act of1934 fromtheir obligations under those Sections. Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) ofthe Securities Exchange Act of1934 during the preceding 12 months (or for such s... |
1 | 172762682_b0 | 172762682 | 2.04
Weighted Average Exercise Price, exercised (USD per share) | $
1.93
1.64
Weighted Average Exercise Price, ending balance (USD per share) | $
$ 2.41
$ 2.21
Class B ordinary shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Shares Available for Grant, beginning balan... |
1 | 172762682_b1 | 172762682 | 61 354,112 $ 0.60 3.07
$ 0.42
0.66
$ 0.63 520,271 $ 0.63 520,271 $ 0.63 0.92
12 Months Ended
Share-based Payments Class B activity (Details)
Jun. 30, 2018 Jun. 30, 2017 USD ($) USD ($)
shares
shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Shares Available for Grant, be... |
1 | 172889321_0 | 172889321 | Autolus Therapeutics Plc
Form 20-F
Filed on 23-Nov-2018 Period 30-Sep-2018 Accession number: 0001730463-18-000005
Included Items
1. 20-F 2. EX-2.3: EXHIBIT 2.3 3. EX-12.1: EXHIBIT 12.1 4. EX-12.2: EXHIBIT 12.2 5. EX-13.1: EXHIBIT 13.1 6. EX-15.1: EXHIBIT 15.1 7. XBRL (render)
UNITED STATES SECURITIES AND EXCHANGE C... |
1 | 172889321_1 | 172889321 | TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
for the transition period from
to
OR
o SHELL COMPANYREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
Commission file number: 001-38547
Autolus Therapeutics plc
(Exact name ... |
1 | 172889321_2 | 172889321 | one ordinary share, nominal value $0.000042 per share
Ordinary shares, nominal value $0.000042 per share*
Name of each exchange on which registered The Nasdaq Stock Market LLC
The Nasdaq Stock Market LLC*
* Not for trading, but only in connection with the registration of the American Depositary Shares*
Securities re... |
1 | 172889321_3 | 172889321 | ) has been subject to such filing requirements for the past 90 days.
Yes x No o
Indicate by check mark whether the registrant has submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was requi... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.